{"id":122970,"date":"2023-09-16T21:31:53","date_gmt":"2023-09-17T01:31:53","guid":{"rendered":"https:\/\/v2fr5er78d.funnewsdaily.com\/books\/typhoid-treatment-market-to-reach-4-8billion-globally-by-2032-at-5-1-cagr-allied-market-research\/"},"modified":"2023-09-16T21:31:53","modified_gmt":"2023-09-17T01:31:53","slug":"typhoid-treatment-market-to-reach-4-8billion-globally-by-2032-at-5-1-cagr-allied-market-research","status":"publish","type":"post","link":"https:\/\/v2fr5er78d.funnewsdaily.com\/books\/typhoid-treatment-market-to-reach-4-8billion-globally-by-2032-at-5-1-cagr-allied-market-research\/","title":{"rendered":"Typhoid Treatment Market to Reach $4.8Billion, Globally, by 2032 at 5.1% CAGR: Allied Market Research"},"content":{"rendered":"

<\/p>\n

\n

The growth of the global typhoid treatment market is driven by rise in the prevalence of typhoid infection, availability of generic antibiotics and rise in R&D activities.<\/h2>\n

New Castle, Delaware, Sept. 11, 2023 (GLOBE NEWSWIRE) — Allied Market Research published a report, titled, \u201cTyphoid Treatment Market<\/strong><\/a> by Treatment Type (Antibiotics, Pain Medication, Others), by Route of Administration (Oral, Intravenous), by Distribution Channel (Hospital Pharmacies, Drug stores and retail pharmacies, Online providers): Global Opportunity Analysis and Industry Forecast, 2023\u20132032\u201d<\/strong>. According to the report, the global typhoid treatment market valued for $2.9\u202fbillion in 2022 and is estimated to reach $4.8\u202fbillion by 2032, exhibiting a CAGR of 5.1% from 2023 to 2032.\u202f\u00a0\u00a0<\/p>\n

Request Sample of the Report:\u00a0<\/strong> https:\/\/www.alliedmarketresearch.com\/request-sample\/144871<\/strong><\/a>\u00a0<\/p>\n

Prime determinants of growth<\/strong>\u00a0<\/p>\n

The growing prevalence of typhoid cases, availability of generic medications and growing focus on research and development by the key players are the factors that drive the growth of the global typhoid treatment market. However, time-consuming approvals and the development of antibiotic resistance\u202fare hampering the typhoid treatment market growth. On the contrary, growing opportunities in emerging countries during the forecast period.\u202f\u00a0\u00a0<\/p>\n

Report coverage & details:\u202f<\/strong>\u00a0<\/p>\n\n\n\n\n\n\n\n\n\n\n\n\n
Report Coverage<\/strong><\/td>\nDetails<\/strong><\/td>\n<\/tr>\n
\u00a0Forecast Period\u00a0<\/td>\n\u00a02023\u20132032\u202f\u00a0<\/td>\n<\/tr>\n
\u00a0Base Year\u00a0<\/td>\n\u00a02022\u202f<\/td>\n<\/tr>\n
\u00a0Market Size in 2022\u00a0<\/td>\n\u00a0$2.9 billion\u202f\u00a0<\/td>\n<\/tr>\n
\u00a0Market Size in 2032\u00a0<\/td>\n\u00a0$4.8\u202fbillion<\/td>\n<\/tr>\n
\u00a0CAGR\u00a0<\/td>\n\u00a05.1%\u202f\u00a0<\/td>\n<\/tr>\n
\u00a0No. of Pages in Report\u00a0<\/td>\n\u00a0250\u00a0<\/td>\n<\/tr>\n
\u00a0Segments covered\u00a0<\/td>\n\u00a0Treatment type, route of administration, distribution channel and Region\u202f\u00a0<\/td>\n<\/tr>\n
\u00a0Drivers\u00a0\u00a0<\/td>\n\u00a0Rise in the prevalence of typhoid infection\u202f\u00a0<\/p>\n

Availability of generic antibiotics\u202f\u00a0<\/p>\n

Rise in R&D activities\u202f\u00a0<\/p>\n<\/td>\n<\/tr>\n

\u00a0Opportunities\u00a0<\/td>\n\u00a0Growth opportunity in emerging markets\u202f\u202f\u00a0<\/td>\n<\/tr>\n
\u00a0Restraints\u00a0<\/td>\n\u00a0Development of antibiotic resistance\u202f\u202f\u00a0<\/p>\n

Time-consuming approvals\u202f\u00a0<\/p>\n<\/td>\n<\/tr>\n<\/table>\n

Recession Scenario\u202f<\/strong>\u00a0<\/p>\n